Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » AANMS August 2024

AANMS August 2024

  • August 26, 2024

Meredith Cummins, Dana Hart and Kahlia Wolsley attended the Australasian Association of Nuclear Medicine Specialists (AANMS) Theranostics Course 24th and 25th August at W Brisbane Hotel. Kahlia was fortunate enough to receive a Travel Grant to assist with costs associated with attending the course as well as Dana receiving funding to go towards her registration.

The two days consisted of presentations, case studies, research outcomes and panel discussions demonstrating Multidisciplinary Team Management (MDM).

The sessions providing an overview on contemporary Theranostics practices including the rapidly expanding evidence-base supporting PET imaging and radionuclide therapy (including 177Lu-PSMA and 177Lu-DOTATATE) for the personalised treatment of neuroendocrine tumours, prostate cancer and advanced thyroid cancer in a multidisciplinary setting.

The NECA staff enjoyed all the presentation, although in particular the sessions – NETs clinical and imaging, NETs therapy and the highlight being NECA nurse session. The NECA nurse session involved amazing presentations on Carcinoid Heart Disease by Dr Lorcan Ruane, Carcinoid Syndrome/Crisis Management by Dr Nattakorn Dhiantravan, Case Study by Stephania Lindores, a round table discussion with the above presenters and to conclude Meredith Cummins provided a presentation on NECA and current statistics as well as an update on Clinical Trials.

Overall, it was an amazing weekend of learning, presenting and collaborating and the nurses at NECA are ever grateful for the generous donations and support to attend and be present at such a wonderful course.

Share this post

Recent posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025

NECA Strategy Day 2025

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNeuroEndocrine Cancer Australia Celebrates Groundbreaking PBS Recommendation of Life-Changing Treatment for Von Hippel-Lindau (VHL) Patients.
NextMedicines Australia PharmAus2024 event, Parliament House, CanberraNext

Related Posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

NECA Strategy Day 2025

On Wednesday 21 May, NeuroEndocrine Cancer Australia (NECA) hosted our annual Strategy Day in Sydney. It’s the one day each year when our entire team

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin